Navigation Links
Genetic tests advertised directly to the consumer
Date:7/21/2009

Los Angeles, London, New Delhi, Singapore and Washington DC (July 20, 2009) Genetic testing services have recently begun to be advertised directly to the patient, and the results of the consumers' response can affect public health, as well as the future adoption of pharmacogenetic/genomic testing, according to a position paper from the American College of Clinical Pharmacology (ACCP) to be published in the August 2009 issue of the Journal of Clinical Pharmacology. The journal is published on behalf of the ACCP by SAGE.

According to the article, "Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology," prescription medications have been advertised in the US for 10+ years with a defined oversight of the process, however, there's no comparable supervision for advertised genetic testing. In order for the consumer to have a positive experience with choosing genetic testing from advertising, clinical pharmacologists believe that effective governmental oversight is imperative, along with assistance from professional clinicians.

Clinical pharmacologists should also help prepare consumers for possible risks of the tests and work closely with those who are considering taking further action in response to an advertisement of genetic testing, providing the following cautionary advice:

  • Verify with a professional, the information presented in advertisements of genetic testing
  • Seek advice from a genetic clinician, not just a general health care professional
  • Recognize the scientific limitations of each test, especially since the information isn't necessarily translatable when it's time to make therapeutic decisions.
  • Realize that many companies selling genetic testing services do not provide interpretation of results.

Commenting on the expanding frontiers of health professions, the authors conclude, "Clinical pharmacology will have a voice in how the evolving science translates not only into clinical trials and patient care but also into regulations involving the promotion and advertising of all genetic tests. Clinical pharmacologists can help ensure that realistic expectations of genetic tests are communicated, thereby mitigating psychological, social, and medical risks."


'/>"/>

Contact: Jim Gilden
media.inquiries@sagepub.com
SAGE Publications
Source:Eurekalert

Related biology news :

1. Genetic marker linked to problem behaviors in adults with developmental disabilities
2. Preimplantation genetic diagnosis may pose neurological risks
3. New research finds possible genetic link to cause of pregnancy loss and disorders
4. Iowa State University researchers develop process for surgical genetic changes
5. LincRNAs serve as genetic air-traffic controllers
6. Genetic factors implicated in survival gap for breast, ovarian or prostate cancer
7. Genetically engineered mice yield clues to knocking out cancer
8. New test can detect both genetic and chromosomal abnormalities in embryos
9. New, less invasive genetic test greatly improves pregnancy rates in older women with poor prognosis
10. T-STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue
11. Genetic finding could lead to targeted therapy for neuroblastoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016  The Office of ... published "Can CT Scans Enhance or Replace Medico ... potential of supporting or replacing forensic autopsies with ... scan. In response to recommendations made ... exploring using CT scans as a potential component ...
(Date:11/30/2016)... CHICAGO , Nov. 30, 2016  higi ... a new partnership initiative targeting national brands, industry ... and reward their respective audiences for taking steps ... Since its inception in 2012, higi has built ... US, impacting over 38 million people who have ...
(Date:11/28/2016)... 28, 2016 "The biometric ... 16.79%" The biometric system market is in the ... the near future. The biometric system market is expected ... at a CAGR of 16.79% between 2016 and 2022. ... biometric technology in smartphones, rising use of biometric technology ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... Dec. 8, 2016 Savannah River Remediation ... and selected NewTechBio,s NT-MAX Lake & Pond ... beneficial bacteria, in conjunction with Hexa Armor/ Rhombo ... with National Pollutant Discharge Elimination System requirements. ... a steady history of elevated pH levels, above ...
(Date:12/8/2016)... to fuel Philadelphia,s innovative digital ... Southeastern Pennsylvania (" Ben Franklin "); Independence ... Cross; and Safeguard Scientifics ("Safeguard") (NYSE: SFE ... funding initiative over a four year period to grow ... burgeoning economic vitality in digital health, Ben Franklin ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. ... and expansion clinical trial for its lead drug candidate, AC0010, at the World ... trial was to determine the safety, antitumor activity, and recommended phase II dosage ...
Breaking Biology Technology: